Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4846006
Max Phase: Preclinical
Molecular Formula: C52H86N10O12
Molecular Weight: 1043.32
Molecule Type: Unknown
Associated Items:
ID: ALA4846006
Max Phase: Preclinical
Molecular Formula: C52H86N10O12
Molecular Weight: 1043.32
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)N(C)C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C(C)C)N(C)C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC1=O
Standard InChI: InChI=1S/C52H86N10O12/c1-15-30(8)40-47(69)56-36(27-63)45(67)58-42(32(10)17-3)52(74)61(13)43(29(6)7)48(70)54-25-38(65)55-35(23-28(4)5)50(72)62(14)44(33(11)64)49(71)59-41(31(9)16-2)51(73)60(12)37(24-34-21-19-18-20-22-34)46(68)53-26-39(66)57-40/h18-22,28-33,35-37,40-44,63-64H,15-17,23-27H2,1-14H3,(H,53,68)(H,54,70)(H,55,65)(H,56,69)(H,57,66)(H,58,67)(H,59,71)/t30-,31-,32-,33+,35-,36-,37-,40-,41-,42-,43-,44-/m0/s1
Standard InChI Key: IPCZOWDKWCZGNZ-GVIQAERMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1043.32 | Molecular Weight (Monoisotopic): 1042.6427 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Grunwald AL, Cartmell C, Kerr RG.. (2021) Auyuittuqamides A-D, Cyclic Decapeptides from Sesquicillium microsporum RKAG 186 Isolated from Frobisher Bay Sediment., 84 (1.0): [PMID:33356241] [10.1021/acs.jnatprod.0c00966] |
Source(1):